Alterations in prejunctional adrenoceptor function in guinea pig and rat vas deferens after chronic ganglionic blockade.
The purpose of the present study was to test the hypothesis that alterations in nerve impulse traffic can influence the activity of substances which act prejunctionally to alter adrenergic neurotransmission. Measurements of the rapid phasic contraction of the isolated rat or guinea-pig vas deferens to short periods of electrical field stimulation were carried out in tissues obtained from saline- or chorisondamine-treated (8 mg/kg twice daily for 5 days) rats and guinea pigs. The alpha-2 selective agonist and antagonist, clonidine, and yohimbine, respectively, were utilized to assess prejunctional alpha-adrenergic function. It was observed that chronic treatment with chlorisondamine in doses that blocked ganglionic transmission produced a subsensitivity of the prejunctional alpha adrenoceptor system as evidenced by the fact that both the alpha-2 agonist, clonidine, and the alpha-2 antagonist, yohimbine, were less effective in decreasing or increasing nerve-stimulated induced contractions of the vas deferens, respectively. The present results are consistent with the idea that interruption of nerve impulse traffic results in a loss or decrease in the function or prejunctional inhibitory systems. Postjunctional supersensitivity of effector cells is an adaptive change in the direction of compensating for a decline in exposure to the neurotransmitter. The physiological success of the adaptation would be further enhanced by an increase in transmitter release consequent to subsensitivity of the presynaptic feedback inhibition.
D000818:Animals; D002714:Chlorisondamine / Q000494:pharmacology; D003000:Clonidine / Q000494:pharmacology; D004558:Electric Stimulation; D005730:Ganglionic Blockers / Q000494:pharmacology*; D006168:Guinea Pigs; D066298:In Vitro Techniques; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D011941:Receptors, Adrenergic / Q000187:drug effects*; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects*; D011978:Receptors, Nicotinic / Q000187:drug effects; D009435:Synaptic Transmission / Q000187:drug effects*; D014649:Vas Deferens / Q000187:drug effects; D015016:Yohimbine / Q000494:pharmacology
D005730:Ganglionic Blockers; D011941:Receptors, Adrenergic; D011942:Receptors, Adrenergic, alpha; D011978:Receptors, Nicotinic; D015016:Yohimbine; D002714:Chlorisondamine; D003000:Clonidine; D009638:Norepinephrine